These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13495720)

  • 1. [Pharmacological lesions of the central nervous system and serum transaminase activity].
    PELLEGRINI R
    Sperimentale; 1957; 107(4):260-70. PubMed ID: 13495720
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of small doses of sodium bromide following action of liminal doses of narcotics on the higher nervous activity].
    LIUBLINA EI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1957; 7(3):447-50. PubMed ID: 13497287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Distribution of histidine decarboxylase in various regions of the central nervous system and effects of some narcotics and analeptics on enzyme activity].
    KURIAKI K; NAITO T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 232(3):481-6. PubMed ID: 13552726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of detecting and differentiating central nervous effects of drugs in animal experiments with special consideration of behavioral-pharmacologic methods].
    Hoffmeister F; Wuttke W
    Arzneimittelforschung; 1975 Jul; 25(7a):1162-78. PubMed ID: 241358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drugs acting on the central nervous system].
    Recenti Prog Med; 1982 Oct; 73(4):462-478. PubMed ID: 6130574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological study of a new neuroplegic; 8-acetyl-10-(3-dimethylaminopropyl) phenothiazine maleate: CB-1522. I. Toxicity: effects on the central & peripheral nervous systems].
    MERCIER J; SCHMITT J; AUROUSSAEU M; ETZENSPERGER P; BONIFAY D
    Arch Int Pharmacodyn Ther; 1957 Dec; 113(1-2):53-75. PubMed ID: 13509771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Central sympatholytic effects as a basis for comparison of narcotics].
    SCHOETENSACK W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952; 216(1-2):175-6. PubMed ID: 12977293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benzonitrile and derivatives. Synthesis and pharmacological study of alkyl para-cyanophenoxy alkanoates on the central nervous system].
    Kirkiacharian S; Goma JR; Cheav SL; Bretaudeau J; Foussard-Blanpin O
    Ann Pharm Fr; 1989; 47(1):16-23. PubMed ID: 2627099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of 1-2-4-triazine derivatives: action on the central nervous system.
    MANTEGAZZA P; TOMMASINI R; FUSCO R; ROSSI S
    Arch Int Pharmacodyn Ther; 1953 Sep; 95(2):123-52. PubMed ID: 13114948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histochemical study on the activity of GABA alpha-ketoglutaric transaminase in the central nervous system of mammals].
    Rodriguez M; Mateos F; Toledano A
    Ann Histochim; 1968; 13(4):229-45. PubMed ID: 5714674
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies on anethole trithione.
    Ukai Y; Shiraishi M; Takeshita K; Fukui T; Kura K; Kimura K
    Arzneimittelforschung; 1988 Oct; 38(10):1460-5. PubMed ID: 3196385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    J Pharmacol Exp Ther; 1959 Jul; 126(3):223-32. PubMed ID: 13673372
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transaminase activity in certain nervous system diseases in children].
    FOIS A; CATALANO V; FERRI BM
    Rass Studi Psichiatr; 1958; 47(4):508-12. PubMed ID: 13614708
    [No Abstract]   [Full Text] [Related]  

  • 14. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotides and the central effects of opiates: an overview of current research.
    Rosenfeld GC; Strada SJ; Robison GA
    Adv Biochem Psychopharmacol; 1979; 20():261-79. PubMed ID: 38640
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological properties of aminoenanthylic acid].
    Gofman SM
    Farmakol Toksikol; 1968; 31(2):188-9. PubMed ID: 4386316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of serotonin on the central nervous system].
    CAHN J; HEROLD M; GEORGES G; PIERRE R
    Therapie; 1958; 13(3):464-9. PubMed ID: 13603379
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of 21-hydroxypregnanedlone and methylandrostanolone on the central nervous system].
    PIERRE R; CAHN J; HEROLD M; GEORGES G
    Therapie; 1958; 13(3):460-3. PubMed ID: 13603378
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of some effects of 5-hydroxytryptamine on the central nervous system of rabbits].
    BARUCCI M
    Rass Studi Psichiatr; 1956; 45(5):893-8. PubMed ID: 13420490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.